Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

PUBLICATION DATE

11 results
Display

Use of Molecular Imaging in Clinical Drug Development: a Systematic Review

Son H, Jang K, Lee H, Kim SE, Kang KW, Lee H

BACKGROUND: Molecular imaging such as positron emission tomography (PET) and single-photon emission computed tomography (SPECT) can provide the crucial pharmacokinetic-pharmacodynamic information of a drug non-invasively at an early stage of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Perspectives in Radiomics for Personalized Medicine and Theranostics

Ha S

Radiomics handles imaging biomarker from high-throughput feature extraction through complex pattern recognition that is difficult for human to process. Recent medical paradigms are rapidly changing to personalized medicine, including molecular...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Perspectives for Concepts of Individualized Radionuclide Therapy, Molecular Radiotherapy, and Theranostic Approaches

Hosono M

Radionuclide therapy (RNT) stands on the delivery of radiation to tumors or non-tumor target organs using radiopharmaceuticals that are designed to have specific affinity to targets. RNT is recently called...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical Applications of Technetium-99m Quantitative Single-Photon Emission Computed Tomography/Computed Tomography

Lee WW, K-SPECT Group

Single-photon emission computed tomography/computed tomography (SPECT/CT) is an already established nuclear imaging modality. Co-registration of functional information (SPECT) with anatomical images (CT) paved the way to the wider application of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical Personal Connectomics Using Hybrid PET/MRI

Lee DS

Brain connectivity can now be studied with topological analysis using persistent homology. It overcame the arbitrariness of thresholding to make binary graphs for comparison between disease and normal control groups....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Quantitative Imaging of Alpha-Emitting Therapeutic Radiopharmaceuticals

Seo Y

Targeted alpha therapy (TAT) is an active area of drug development as a highly specific and highly potent therapeutic modality that can be applied to many types of late-stage cancers....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Ipsilateral Hyperhidrosis: Atypical Symptom of Small Lung Adenocarcinoma Evaluated by ¹⁸F-FDG PET-CT

Yoo MY, Koong SS, Kim SW, Kim D

A 45-year-old male visited our clinic due to right palmar anhidrosis and contralateral hyperhidrosis. Chest computed tomography (CT) showed a solitary pulmonary nodule with mediastinal lymph node enlargement, but a...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Eruption of Metastatic Paraganglioma After Successful Therapy with ¹⁷⁷Lu/⁹⁰Y-DOTATOC and ¹⁷⁷Lu-DOTATATE

Wolf KI, Jha A, van Berkel A, Wild D, Janssen I, Millo CM, Janssen M, Gonzales M, Timmers HJ, Pacak K

Metastatic paraganglioma treatment options are limited. Peptide receptor radionuclide therapy (PRRT) has been introduced as a novel management option for metastatic neuroendocrine tumors demonstrating safety, efficacy, and increased quality of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
How Do the More Recent Reconstruction Algorithms Affect the Interpretation Criteria of PET/CT Images?

Matti A, Lima GM, Pettinato , Pietrobon , Martinelli F, Fanti S

PURPOSE: Recently, a new Bayesian Penalized Likelihood (BPL) Reconstruction Algorithm was introduced by GE Healthcare, Q.Clear; it promises to provide better PET image resolution compared to the widely used Ordered...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Lesion-Wise Comparison of Pre-Therapy and Post-Therapy Effective Half-Life of Iodine-131 in Pediatric and Young Adult Patients with Differentiated Thyroid Cancer Undergoing Radioiodine Therapy

Kumar P, Bal C, Damle NA, Ballal S, Dwivedi SN, Agarwala S

PURPOSE: The effective half-life of radioiodine is an important parameter for dosimetry in differentiated thyroid cancer patients, particularly in children. We determined the pre-therapy and post-therapy effective half-life in different...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Development of a Novel Imaging Agent for Determining Albumin Uptake in Solid Tumors

Daum S, Magnusson , Pes L, Garcia Fernandez J, Chercheja , Medda F, Nollmann F, Koester SD, Perez Galan P, Warnecke A, Abu Ajaj K, Kratz F

PURPOSE: The purpose of this study was to investigate the albumin-binding compound 111In-C4-DTPA as an imaging agent for the detection of endogenous albumin accumulation in tumors. METHODS: 111In-C4-DTPA was injected in...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr